Allogene Therapeutics, Inc. (ALLO)

CIK 1737287 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Allogene Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Nov 5, 20268-K0001628280-26-071040
Oct 27, 2026SCHEDULE 13G/A0002012383-26-003872
Oct 23, 202640001491874-26-000005
Oct 21, 20261440001491874-26-000003
Sep 30, 2026SCHEDULE 13D/A0001999371-26-021654
Sep 2, 20268-K0001193125-26-379423
Aug 25, 202640001628280-26-058920
Aug 21, 20261440001737287-26-000023
Aug 20, 2026EFFECT9999999995-26-002725
Aug 14, 2026SCHEDULE 13G/A0001231919-26-000912
Aug 12, 202610-Q0001628280-26-056213
Aug 12, 20268-K0001628280-26-056198
Aug 12, 2026S-30001628280-26-056232
Aug 7, 2026SCHEDULE 13G/A0001296549-26-000008
Aug 7, 2026SCHEDULE 13G0000093751-26-000405
Jul 6, 202640001851044-26-000005
Jun 23, 202640001548072-26-000002
Jun 23, 202640001197020-26-000002
Jun 23, 202640001221355-26-000002
Jun 23, 202640001737287-26-000021
Jun 23, 202640001737287-26-000019
Jun 23, 202640001700969-26-000002
Jun 23, 202640001764157-26-000004
Jun 22, 20268-K0001628280-26-044618
Jun 22, 2026424B50001628280-26-044616